Literature DB >> 3813596

Scleredema and paraproteinemia. Enhanced collagen production and elevated type I procollagen messenger RNA level in fibroblasts grown from cultures from the fibrotic skin of a patient.

A Oikarinen, L Ala-Kokko, R Palatsi, L Peltonen, J Uitto.   

Abstract

An edematous rash developed on the abdominal skin of a 76-year-old woman who had had diabetes mellitus for ten years. Some months later, the affected skin became thickened and indurated. Histopathologic examination revealed marked dermal fibrosis with excessive deposition of collagen. The patient also had IgA (k-type) paraproteinemia. Fibroblast cultures from the affected and unaffected skin were studied for collagen metabolism. Procollagen synthesis was elevated about sixfold on fibroblasts derived from the affected skin. A similar increase was detected in messenger RNA (mRNA) levels using a complementary DNA clone specific for human pro alpha 1(l) collagen mRNA. The elevated mRNA level could be the result of increased transcriptional activity of collagen genes or decreased degradation of collagen mRNAs. Our findings suggest that increased collagen deposition may account for the marked dermal fibrosis that we observed in this patient.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3813596     DOI: 10.1001/archderm.123.2.226

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

1.  Scleredema adultorum: quali-quantitative analysis of collagen fibers.

Authors:  M Carlesimo; A Gamba; M La Pietra; A Arcese; D Orsini; G Cortesi; S Raffa; M R Torrisi; G Camplone
Journal:  J Endocrinol Invest       Date:  2011-09       Impact factor: 4.256

Review 2.  From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature.

Authors:  Magdalena Dziadzio; Constantinos P Anastassiades; Philip N Hawkins; Michael Potter; Armando Gabrielli; Geraldine M Brough; Carol M Black; Christopher P Denton
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.